NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW)
Historical Holders from Q2 2022 to Q3 2025
-
Type / Class
-
Equity / *W EXP 99/99/999
-
Symbol
-
NAMSW on Nasdaq
-
Price per share
-
$17.11
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares as of 30 Sep 2025
-
1,299,513
-
Holdings value
-
$22,235,865
-
% of all portfolios
-
0%
-
Share change
-
-4,322
-
Value change
-
-$56,301
-
Average sells %
-
-0%
-
Number of holders
-
9
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
As of 30 Sep 2025, NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW) has 9 institutional shareholders filing 13F forms.
They hold 1,299,513 shares
.
Institutional Holders of NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW) across Reporting Periods
| Period |
Reported Shares, Excl. Options |
Value, Excl. Options |
Value Change |
Puts Notional Value |
Calls Notional Value |
Price |
Investors |
|
2025 Q3
|
1,299,513 |
$22,235,865 |
-$56,301 |
|
$1,283,250 |
$17.11 |
9 |
|
2025 Q2
|
1,303,835 |
$10,430,849 |
-$24,954 |
|
$600,000 |
$8.00 |
10 |
|
2025 Q1
|
1,306,973 |
$12,322,274 |
-$180,493 |
|
$674,250 |
$8.99 |
10 |
|
2024 Q4
|
1,320,515 |
$18,754,055 |
+$115,750 |
|
$1,068,750 |
$14.25 |
11 |
|
2024 Q3
|
1,331,215 |
$9,317,371 |
+$241,907 |
|
$525,000 |
$7.00 |
12 |
|
2024 Q2
|
1,296,671 |
$11,487,041 |
-$1,594,623 |
|
$654,000 |
$8.72 |
11 |
|
2024 Q1
|
1,439,010 |
$15,885,834 |
+$1,340,436 |
|
$828,000 |
$11.04 |
12 |
|
2023 Q4
|
8,993 |
$28,148 |
-$13,991 |
|
|
$3.13 |
1 |
|
2023 Q3
|
1,605,578 |
$3,494,157 |
-$577,328 |
|
$142,500 |
$1.90 |
19 |
|
2023 Q2
|
1,884,490 |
$3,937,579 |
-$678,321 |
|
$156,750 |
$2.09 |
18 |
|
2023 Q1
|
2,231,947 |
$1,359,753 |
+$51,692 |
|
$138,000 |
$0.001800 |
19 |
|
2022 Q4
|
2,281,964 |
$565,340 |
+$565,378 |
|
$65,000 |
$0.000800 |
20 |
|
2022 Q3
|
0 |
$0 |
-$35,530 |
|
|
|
0 |
|
2022 Q2
|
17,000 |
$35,530 |
+$35,530 |
|
|
$2.09 |
1 |